Matches in Wikidata for { <http://www.wikidata.org/entity/Q105789191> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q105789191 description "clinical trial" @default.
- Q105789191 description "ensayo clínico" @default.
- Q105789191 description "ensayu clínicu" @default.
- Q105789191 description "klinisch onderzoek" @default.
- Q105789191 description "клінічне випробування" @default.
- Q105789191 description "临床试验" @default.
- Q105789191 name "Androgen Deprivation Therapy and Apalutamide With or Without Radiation Therapy for the Treatment of Biochemically Recurrent Prostate Cancer, RESTART Study" @default.
- Q105789191 name "Androgen Deprivation Therapy and Apalutamide With or Without Radiation Therapy for the Treatment of Biochemically Recurrent Prostate Cancer, RESTART Study" @default.
- Q105789191 type Item @default.
- Q105789191 label "Androgen Deprivation Therapy and Apalutamide With or Without Radiation Therapy for the Treatment of Biochemically Recurrent Prostate Cancer, RESTART Study" @default.
- Q105789191 label "Androgen Deprivation Therapy and Apalutamide With or Without Radiation Therapy for the Treatment of Biochemically Recurrent Prostate Cancer, RESTART Study" @default.
- Q105789191 prefLabel "Androgen Deprivation Therapy and Apalutamide With or Without Radiation Therapy for the Treatment of Biochemically Recurrent Prostate Cancer, RESTART Study" @default.
- Q105789191 prefLabel "Androgen Deprivation Therapy and Apalutamide With or Without Radiation Therapy for the Treatment of Biochemically Recurrent Prostate Cancer, RESTART Study" @default.
- Q105789191 P1050 Q105789191-41ABE732-9832-49BF-BFFD-D662DB61ECA1 @default.
- Q105789191 P1132 Q105789191-BE560CAD-58DE-4DB5-A062-2207C9109EB7 @default.
- Q105789191 P1476 Q105789191-9D6FE1B8-224F-43FF-96E1-AB04F838C8E6 @default.
- Q105789191 P17 Q105789191-8F9BFEAF-2090-4CC4-945B-610AC5B2C005 @default.
- Q105789191 P2899 Q105789191-ED0A0743-6872-418B-8FC3-BAC4C69AA659 @default.
- Q105789191 P3098 Q105789191-41FAB729-EBE9-4F29-8367-4DBCDFCE2E77 @default.
- Q105789191 P31 Q105789191-203146E2-9A10-4A74-BAAA-660C1A325497 @default.
- Q105789191 P4844 Q105789191-41C8FBB9-AD9C-4FA0-AE10-1651AA7145D4 @default.
- Q105789191 P580 Q105789191-FE687D4E-7EB9-4322-9B43-BED712F7B46A @default.
- Q105789191 P582 Q105789191-250B7819-08BA-4BD3-863E-B1206E080F63 @default.
- Q105789191 P6099 Q105789191-F59C32C0-6761-452C-98CA-176772B1AB82 @default.
- Q105789191 P767 Q105789191-E8F940E4-9494-4A79-9913-66A131C2AB38 @default.
- Q105789191 P8005 Q105789191-F2D3AB4C-C0B3-4CE5-9C5A-8F43B0BEA809 @default.
- Q105789191 P8363 Q105789191-19405A22-C261-489E-9F3C-0B55628FC3DC @default.
- Q105789191 P859 Q105789191-26DD046C-617D-4622-89C3-2C553AF6B291 @default.
- Q105789191 P1050 Q33525 @default.
- Q105789191 P1132 "+0" @default.
- Q105789191 P1476 "Phase 2 Response Evaluation of Finite Systemic Therapy With Advanced Androgen Signaling Inhibition and Radiation Therapy for Oligorecurrent Prostate Cancer (RESTART)" @default.
- Q105789191 P17 Q30 @default.
- Q105789191 P2899 "+18" @default.
- Q105789191 P3098 "NCT04585932" @default.
- Q105789191 P31 Q30612 @default.
- Q105789191 P4844 Q907160 @default.
- Q105789191 P580 "2020-11-24T00:00:00Z" @default.
- Q105789191 P582 "2021-01-08T00:00:00Z" @default.
- Q105789191 P6099 Q42824440 @default.
- Q105789191 P767 Q664846 @default.
- Q105789191 P8005 Q76650124 @default.
- Q105789191 P8363 Q78089383 @default.
- Q105789191 P859 Q1525831 @default.